Resumen

ARIAS SOSA, Luis Alejandro. Use of microRNAs in heart failure management. Arch. Cardiol. Méx. [online]. 2017, vol.87, n.3, pp.205-224. ISSN 1665-1731.  https://doi.org/10.1016/j.acmx.2017.02.003.

Heart failure (HF) is a high impact disease that affects all human populations, demanding the development of new strategies and methods to manage this pathology. That’s why microRNAs, small noncoding RNAs that regulate gene expression, appear as an important option in the diagnosis, prognosis and treatment of this disease. MiRNAs seems to have a future on HF handling, because can be isolated from body fluids such as blood, and changes in its levels can be associated with the presence, stage and specific disease features, which makes them an interesting option as biomarkers. Also, due to the important role of these molecules on regulation of gene expression and cell homeostasis, it has been explored its potential use as a therapeutic method to prevent or treat HF. That is why this review seeks to show the importance of biomedical research involving the use of miRNAs as a method to approach the HF, showing the impact of disease in the world, aspects of miRNAs biology, and their use as biomarkers and as important therapeutic targets.

Palabras llave : Arrhythmias; Cardiac remodeling; Heart failure; Micro RNAs; Regeneration; Colombia.

        · resumen en Español     · texto en Español     · Español ( pdf )